| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Trade Desk, Inc. | Director | Class A Common Stock | 105K | $6.2M | $59.17 | May 27, 2025 | Direct |
| Trade Desk, Inc. | Director | Class A Common Stock | 50K | $2.7M | $53.97 | May 27, 2025 | By Family Trust |
| Arcus Biosciences, Inc. | Director | Common Stock | 102K | $829K | $8.12 | Jun 10, 2025 | By Trust |
| Arcus Biosciences, Inc. | Director | Common Stock | 68.6K | $557K | $8.12 | Jun 10, 2025 | Direct |
| Nuvation Bio Inc. | Director | Stock Option (Right to Buy) | 293K | May 21, 2025 | Direct | ||
| Arcus Biosciences, Inc. | Director | Stock Option (Rights to Buy) | 38.3K | Jun 10, 2025 | Direct | ||
| Tricida, Inc. | Director | Stock Option (right to buy) | 27.2K | Jun 15, 2022 | Direct | ||
| UroGen Pharma Ltd. | Director | Stock Option (right to buy) | 10K | Jun 7, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | Jun 10, 2025 | 2 | $0 | 4 | Jun 12, 2025 | Director |
| TTD | Trade Desk, Inc. | May 27, 2025 | 4 | $170K | 4 | May 29, 2025 | Director |
| NUVB | Nuvation Bio Inc. | May 21, 2025 | 1 | $0 | 4 | May 23, 2025 | Director |
| TTD | Trade Desk, Inc. | Apr 15, 2025 | 1 | $5.74K | 4 | Apr 17, 2025 | Director |
| NUVB | Nuvation Bio Inc. | Sep 3, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
| TTD | Trade Desk, Inc. | Aug 13, 2024 | 1 | -$14.7M | 4 | Aug 15, 2024 | Director |
| RCUS | Arcus Biosciences, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| TTD | Trade Desk, Inc. | May 28, 2024 | 3 | $99.9K | 4 | May 30, 2024 | Director |
| TTD | Trade Desk, Inc. | Mar 8, 2024 | 6 | -$8.25M | 4 | Mar 12, 2024 | Director |
| RCUS | Arcus Biosciences, Inc. | Jun 15, 2023 | 3 | $0 | 4 | Jun 16, 2023 | Director |
| TTD | Trade Desk, Inc. | May 25, 2023 | 3 | $99.9K | 4 | May 30, 2023 | Director |
| NUVB | Nuvation Bio Inc. | May 15, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
| TTD | Trade Desk, Inc. | Feb 6, 2023 | 0 | $0 | 4/A | Feb 9, 2023 | Director |
| NUVB | Nuvation Bio Inc. | Nov 30, 2022 | 4 | $484K | 4 | Dec 5, 2022 | Director |
| TCDA | Tricida, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| RCUS | Arcus Biosciences, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
| TTD | Trade Desk, Inc. | May 26, 2022 | 4 | $70.9K | 4 | May 31, 2022 | Director |
| NUVB | Nuvation Bio Inc. | May 16, 2022 | 1 | $0 | 4/A | Jun 28, 2022 | Director |
| TTD | Trade Desk, Inc. | Nov 19, 2021 | 4 | -$16.3M | 4 | Nov 23, 2021 | Director |
| NUVB | Nuvation Bio Inc. | Oct 29, 2021 | 1 | $0 | 4 | Nov 2, 2021 | Director |
| TCDA | Tricida, Inc. | Jun 10, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director |
| URGN | UroGen Pharma Ltd. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
| RCUS | Arcus Biosciences, Inc. | Jun 3, 2021 | 2 | $0 | 4 | Jun 7, 2021 | Director |
| TTD | Trade Desk, Inc. | May 27, 2021 | 4 | $70.4K | 4 | Jun 1, 2021 | Director |